Thierry MARTENS

Person

La Queue En Brie, FR

People

Patents Grantslast 30 patents

Information Patent Grant
Highly efficient NRF2 activators-co-releasing molecule hybrids, the...
- Patent number 10,519,179
- Issue date Dec 31, 2019
- Centre National de la Recherche Scientifique
- Roberto Motterlini
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Derivatives of oxazaphosphorines that are pre-activated, use and me...
- Patent number 10,125,157
- Issue date Nov 13, 2018
- Institut Gustave Roussy
- Angelo Paci
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Derivatives of oxazaphosphorines and therapeutic uses thereof
- Patent number 10,098,901
- Issue date Oct 16, 2018
- Institut Gustave Roussy
- Angelo Paci
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fumarate-CO-releasing molecule hybrids, their use in the treatment...
- Patent number 9,944,669
- Issue date Apr 17, 2018
- Universite Paris-EST Creteil val de Marne
- Roberto Motterlini
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Chemical model of a neurodegenerative disease, method for preparati...
- Patent number 9,744,250
- Issue date Aug 29, 2017
- Centre National de la Recherche Scientifique
- Thierry Martens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Derivatives of oxazaphosphorines that are pre-activated, use and me...
- Patent number 9,428,530
- Issue date Aug 30, 2016
- Institut Gustave Roussy
- Angelo Paci
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Derivatives of oxazaphosphorines that are pre-activated, use and me...
- Patent number 9,073,957
- Issue date Jul 7, 2015
- Institut Gustave Roussy
- Angelo Paci
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
HIGHLY EFFICIENT NRF2 ACTIVATORS-CO-RELEASING MOLECULE HYBRIDS, THE...
- Publication number 20180258121
- Publication date Sep 13, 2018
- CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
- Roberto MOTTERLINI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CHEMICAL MODEL OF A NEURODEGENERATIVE DISEASE, METHOD FOR PREPARATI...
- Publication number 20170360964
- Publication date Dec 21, 2017
- Centre National de la Recherche Scientifique
- THIERRY MARTENS
- G01 - MEASURING TESTING
Information Patent Application
FUMARATE-CO-RELEASING MOLECULE HYBRIDS, THEIR USE IN THE TREATMENT...
- Publication number 20170174716
- Publication date Jun 22, 2017
- UNIVERSITE PARIS-EST CRETEIL VAL DE MARNE
- Roberto MOTTERLINI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL DERIVATIVES OF OXAZAPHOSPHORINES AND THERAPEUTIC USES THEREOF
- Publication number 20170071959
- Publication date Mar 16, 2017
- ANGELO PACI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL DERIVATIVES OF OXAZAPHOSPHORINES THAT ARE PRE-ACTIVATED, USE...
- Publication number 20160333038
- Publication date Nov 17, 2016
- INSTITUT GUSTAVE ROUSSY
- ANGELO PACI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CHEMICAL MODEL OF A NEURODEGENERATIVE DISEASE, METHOD FOR PREPARATI...
- Publication number 20150328338
- Publication date Nov 19, 2015
- Centre National de la Recherche Scientifique
- THIERRY MARTENS
- G01 - MEASURING TESTING
Information Patent Application
NOVEL DERIVATIVES OF OXAZAPHOSPHORINES THAT ARE PRE-ACTIVATED, USE...
- Publication number 20150315220
- Publication date Nov 5, 2015
- INSTITUT GUSTAVE ROUSSY
- ANGELO PACI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL DERIVATIVES OF OXAZAPHOSPHORINES THAT ARE PRE-ACTIVATED, USE...
- Publication number 20130261088
- Publication date Oct 3, 2013
- INSTITUT GUSTAVE ROUSSY
- Angelo Paci
- C07 - ORGANIC CHEMISTRY

Thierry MARTENS

Person

Patents Grantslast 30 patents

Highly efficient NRF2 activators-co-releasing molecule hybrids, the...

Derivatives of oxazaphosphorines that are pre-activated, use and me...

Derivatives of oxazaphosphorines and therapeutic uses thereof

Fumarate-CO-releasing molecule hybrids, their use in the treatment...

Chemical model of a neurodegenerative disease, method for preparati...

Derivatives of oxazaphosphorines that are pre-activated, use and me...

Derivatives of oxazaphosphorines that are pre-activated, use and me...

Patents Applicationslast 30 patents

HIGHLY EFFICIENT NRF2 ACTIVATORS-CO-RELEASING MOLECULE HYBRIDS, THE...

CHEMICAL MODEL OF A NEURODEGENERATIVE DISEASE, METHOD FOR PREPARATI...

FUMARATE-CO-RELEASING MOLECULE HYBRIDS, THEIR USE IN THE TREATMENT...

NOVEL DERIVATIVES OF OXAZAPHOSPHORINES AND THERAPEUTIC USES THEREOF

NOVEL DERIVATIVES OF OXAZAPHOSPHORINES THAT ARE PRE-ACTIVATED, USE...

CHEMICAL MODEL OF A NEURODEGENERATIVE DISEASE, METHOD FOR PREPARATI...

NOVEL DERIVATIVES OF OXAZAPHOSPHORINES THAT ARE PRE-ACTIVATED, USE...

NOVEL DERIVATIVES OF OXAZAPHOSPHORINES THAT ARE PRE-ACTIVATED, USE...